Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
53%
Total
Publications
266
Total Open
Publications
142
Total
Citations
12K
Open Access
Percentage
53%
Total
Publications
266
Total Open
Publications
142
Total
Citations
12K
Breakdown
Publisher Open
25%
Both
18%
Other Platform Open
10%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
27
Hybrid 32%
37
No Guarantees 44%
51
Other Platform Open
Domain 80%
60
Institution 20%
15
Preprint 16%
12
Other Internet 15%
11
Public 9%
7
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 60 |
Europe PMC | Domain | 35 |
Research Square | Preprint | 8 |
Semantic Scholar | Public | 7 |
DOI | Other Internet | 4 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 3 |
The University of Manchester - Research Explorer | Institution | 2 |
California Digital Library - eScholarship | Other Internet | 2 |
Unknown Repository | Other Internet | 1 |
University of Tasmania - eCite Digital Repository | Institution | 1 |